Dermatomyositis: Modern Diagnostic Paradigms

This 2025 academic review provides a comprehensive update on dermatomyositis (DM), an inflammatory disease primarily affecting the skin and skeletal muscles. The authors emphasize that specific skin lesions, such as Gottron papules and the heliotrope rash, are vital for early diagnosis and can signal serious risks like malignancy or lung disease. A major focus is placed on myositis-specific autoantibodies, which help clinicians predict disease severity and tailor treatments to individual patient profiles. Diagnostic advancements highlighted include muscle MRI patterning and MxA immunohistochemistry, which offer greater precision than traditional blood tests alone. Management strategies have shifted toward early immunosuppression, including the use of IVIG and JAK inhibitors to improve long-term outcomes. Ultimately, the source advocates for a multidisciplinary approach to address the complex systemic complications associated with this condition.